Table 1.
Lipid and lipid metabolites that contribute to podocyte lipotoxicity
| Class | Model | Outcome | Ref. |
|---|---|---|---|
| Saturated FAs | |||
| Palmitic acid (16:0)* | MPC, DKD mice | ↑ Podocyte injury and apoptosis, mitochondrial dysfunction, oxidative stress, ER stress, insulin resistance; ↑ albuminuria | [27–32] |
| Stearic acid (18:0)* | CKD patients | Decreased abundance in plasma associate with declining renal function | [33] |
| Unsaturated FAs | |||
| Oleic acid (18:1)* | MPC, DKD mice | ↓ Podocytes cell death and loss, ER stress, oxidative stress; ↑ proteasome expression; ↓ albuminuria, histologic changes | [28, 34] |
| Arachidonic acid (20:4)* | HPC | ↑ Actin cytoskeleton remodeling, podocyte injury | [35] |
| Eicosapentaenoic acid (20:5)* | MPC | ↓ Podocyte apoptosis, inflammation | [36] |
| Glycerolipids | |||
| Triglyceride | CKD, metabolic syndrome mice | ↑ Podocyte apoptosis; ↑ albuminuria, histologic changes | [37] |
| Phospholipids | |||
| Phosphatidylcholine | MPC, DKD mice | Associate with podocyte injury and DKD | [38, 39] |
| Phosphatidylethanolamine | MPC, DKD mice | Associate with podocyte injury and DKD | [38, 39] |
| Cardiolipin | HPC, DKD mice | ↑ Podocyte injury, mitochondrial dysfunction; ↑ albuminuria, histologic changes | [25] |
| Phosphosphingolipids | |||
| Sphingomyelin | DKD mice | ↑ Actin cytoskeleton remodeling, podocyte injury; ↑ albuminuria, histologic changes | [40] |
| Glycosphingolipids | |||
| Ganglioside | HPC, MPC, DKD mice | ↑ Actin cytoskeleton remodeling, podocyte injury; ↑ albuminuria, histologic changes | [41, 42, 43] |
| Other sphingolipids | |||
| Ceramide | DKD mice | ↑ Mitochondrial dysfunction, inflammation, insulin resistance, podocyte injury | [42, 44, 45] |
| Sphingosine | Primary MPC, podocytopathy and associated NS mice (Asah1fl/fl/Podo-Cre mice) | ↓ Exosome release of podocytes, podocyte injury; ↓ urinary exosome excretion | [46, 47] |
| Sphingosine-1-phosphate | CKD mice | ↑ Albuminuria, histological changes; ↑ oxidative stress, mitochondrial dysfunction | [46, 48] |
| Ceramide-1-phosphate | HPC, DKD mice | ↓ Inflammation, insulin resistance, podocyte apoptosis; ↓ albuminuria, histologic changes | [25, 40] |
| Sterol lipid | |||
| Cholesterol | HPC, HN mice | ↑ Podocyte apoptosis; ↑ albuminuria, histologic changes | [49, 50] |
| Cholesterol esters | HPC, DKD mice, AS mice | ↑ Podocyte injury; ↑ albuminuria, histologic changes | [51] |
Ref., reference; MPC, mouse podocytes; DKD, diabetic kidney disease; CKD, chronic kidney disease; ER, endoplasmic reticulum; HPC, human podocytes; NS, nephrotic syndrome; KO, knockout; Podo, podocyte; HN, hypertensive nephropathy; AS, Alport syndrome. * Number of carbon atoms: number of C = C double bonds.